These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11337496)

  • 1. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).
    Lai A; Sarcevic B; Prall OW; Sutherland RL
    J Biol Chem; 2001 Jul; 276(28):25823-33. PubMed ID: 11337496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
    Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
    Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
    Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS; Prall OW; Musgrove EA; Sutherland RL
    J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.
    Prall OW; Carroll JS; Sutherland RL
    J Biol Chem; 2001 Nov; 276(48):45433-42. PubMed ID: 11581254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
    Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
    Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).
    Greeve MA; Allan RK; Harvey JM; Bentel JM
    J Mol Endocrinol; 2004 Jun; 32(3):793-810. PubMed ID: 15171713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD; Weinberg RA
    Mol Cell Biol; 1997 Jul; 17(7):4059-69. PubMed ID: 9199341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
    Dees C; Garrett S; Henley D; Travis C
    Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.
    Stewart ZA; Leach SD; Pietenpol JA
    Mol Cell Biol; 1999 Jan; 19(1):205-15. PubMed ID: 9858545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1).
    Gentilini G; Kirschbaum NE; Augustine JA; Aster RH; Visentin GP
    Blood; 1999 Jan; 93(1):25-33. PubMed ID: 9864142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.